What Does the Boxed Warning Tell Us? Safe Practice of Using Ferumoxytol as an MRI Contrast Agent

BACKGROUND AND PURPOSE: Despite the label change and the FDA's boxed warning added to the Feraheme (ferumoxytol) label in March 2015, radiologists have shown increasing interest in using ferumoxytol as an MR imaging contrast agent as a supplement or alternative to gadolinium. The goals of this...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:AJNR Am J Neuroradiol
Hlavní autoři: Varallyay, C.G., Toth, G.B., Fu, R., Netto, J.P., Firkins, J., Ambady, P., Neuwelt, E.A.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Neuroradiology 2017
Témata:
Patient Safety
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5509484/
https://ncbi.nlm.nih.gov/pubmed/28495944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A5188
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky